Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TT3K
|
|||
| Former ID |
DNC010755
|
|||
| Drug Name |
NSC-645811
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H22N4O2
|
|||
| Canonical SMILES |
CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=CC(=O)C=CC4=C2O
|
|||
| InChI |
1S/C20H22N4O2/c1-3-23(4-2)10-9-21-15-7-8-16-19-18(15)20(26)14-6-5-13(25)11-17(14)24(19)12-22-16/h5-8,11-12,21,26H,3-4,9-10H2,1-2H3
|
|||
| InChIKey |
VCSROMHSGSVBHE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Quinone reductase 2 (NQO2) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Imidazoacridin-6-ones as novel inhibitors of the quinone oxidoreductase NQO2. Bioorg Med Chem Lett. 2010 May 1;20(9):2832-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.